Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00673322 · ClinicalTrials.gov registry record · Phase 1
Trial of Second Generation Designer T Cells in Colorectal Carcinoma
A Phase 1 study, sponsored by Roger Williams Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00673322: Clinical Trial Phase 1 study, sponsored by Roger Williams Medical Center.
NCT00673322 is a Phase 1 study that was terminated before completion, run by Roger Williams Medical Center. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00673322, a Phase 1 study, was terminated before completion, sponsored by Roger Williams Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data on the safety and effectiveness of 2nd generation designer T cells in patients with colorectal cancer. Designer T cells are prepared by collecting white blood cells from the participant, and then modifying these cells in the laboratory so that they recognize the tumor antigen (CEA). These modified cells are then given back into the participant so that they can attack and kill tumor cells.
Interventions
- BIOLOGICAL Gene Modified T Cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Why NCT00673322 stopped before completion
NCT00673322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Gene Modified T Cells is the first listed.
NCT00673322 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00673322 about?
NCT00673322 is a clinical study titled "Trial of Second Generation Designer T Cells in Colorectal Carcinoma". The purpose of this study is to collect data on the safety and effectiveness of 2nd generation designer T cells in patients with colorectal cancer. Designer T cells are prepared by collecting white blood cells from the participant, and then modifying these cells in the laboratory so that they recogn...
What is the current status of trial NCT00673322?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2008-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00673322?
The interventions under investigation include: Gene Modified T Cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT00673322?
This trial is sponsored by Roger Williams Medical Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00673322's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia